Key facts and Forecast
Results of Q2 2022
- Group net sales rise by 14.3% to € 5.6 billion
- All business sectors contribute to strong organic sales growth of 6.6%, especially the “Big 3” growth drivers
- EBITDA pre up by 13.1% to € 1.8 billion; EBITDA pre margin at 32.0%
- Cost inflation is partly offset by price increases
Forecast for fiscal 2022
- Guidance for Group organic growth confirmed
- Stronger positive currency effects expected for fiscal 2022
Company performance in Q2 2022
Q2 2022 (in € billion) | Change (in %, compared to Q2 2021) | Organic growth (in %, compared to Q2 2021) | |
---|---|---|---|
Group net sales: |
5.6 |
14.3 |
6.6 |
EBITDA pre: |
1.8 |
13.1 |
3.2 |
Life Science sales: |
2.6 |
19.0 |
10.4 |
Healthcare sales: |
1.9 |
7.6 |
1.4 |
Electronics sales: |
€ 996 million |
16.3 |
7.4 |
Q2 2022 underlines the resilience of our strategy to generate growth and with that, value for our patients and customers.
Q2 2022 in summary
Overview by CFO Marcus Kuhnert.
-
Half-Yearly Financial Report 2022 (PDF)
Download (PDF)Detailed information about our business in the first half of 2022.
ADDITIONAL INFORMATION
Downloads for the Media
Additional Downloads
- Presentation for Analysts (PDF)
- Financial Statement (XLS)
- Financial Statement (PDF)
- Regional Sector Sales (XLS)
- Summary (PDF)
Recording
- The conference call for the media and the conference call for analysts are available as a recording
Related News
View All News-
Press Releases
Q2 2022: Merck KGaA, Darmstadt, Germany, Delivers Robust Growth Despite Headwinds
Merck KGaA, Darmstadt, Germany, continued its growth trajectory in the second quarter of 2022 despite a challenging environment. Net sales increased by 14.3% compared with the second quarter of 2021 to ...
2022/08/04
Upcoming Events
View All Events06 Oct 2022
Capital Markets Day 2022
Our Capital Markets Day 2022 is taking place on Thursday, October 6, 2022.
Our Q3 2022 results will be published on November 10, 2022, at 7 a.m. (CET). Our conference call for the media will take place at 9:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
Check Share Price